Serum S100β Protein as a Marker of Disease Activity in Patients with Malignant Melanoma

By Mohammed M.Q.   Abraha H.D.   Sherwood R.A.   MacRae K.   Retsas S.  

Medical Oncology, Vol. 18, Iss. 2, 2001-03 ,pp. : 109-120

Humana Press, Inc

Access to resources Recommend Favorite

Melanoma

By  

Current Cancer Therapy Reviews, Vol. 12, Iss. 3, 2017-02 ,pp. : 172-203

Bentham Science Publishers

Access to resources Recommend Favorite

Serum VEGF-C is associated with metastatic site in patients with malignant melanoma

By Vihinen Pia P.   Hilli Johanna   Vuoristo Meri-Sisko   Syrjänen Kari J.   Kähäri Veli-Matti   Pyrhönen Seppo O.  

Acta Oncologica, Vol. 46, Iss. 5, 2007-01 ,pp. : 678-684

Informa Healthcare

Access to resources Recommend Favorite

Detection of First Relapse in Cutaneous Melanoma Patients: Implications for the Formulation of Evidence-Based Follow-up Guidelines

By Francken Anne   Shaw Helen   Accortt Neil   Soong Seng-Jaw   Hoekstra Harald   Thompson John  

Annals of Surgical Oncology, Vol. 14, Iss. 6, 2007-06 ,pp. : 1924-1933

Springer Publishing Company

Access to resources Recommend Favorite

Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients

By Benlalam Houssem   Vignard Virginie   Khammari Amir   Bonnin Annabelle   Godet Yann   Pandolfino Marie-Christine   Jotereau Francine   Dreno Brigitte   Labarrière Nathalie  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 4, 2007-04 ,pp. : 515-526

Springer Publishing Company

Access to resources Recommend Favorite